SELENOV

gene
On this page

Also known as SELV

Summary

SELENOV (selenoprotein V, HGNC:30399) is a protein-coding gene on chromosome 19q13.2, encoding Selenoprotein V (P59797). May be involved in a redox-related process.

This gene encodes a selenoprotein containing a selenocysteine (Sec) residue, which is encoded by the UGA codon that normally signals translation termination. The 3’ UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. This protein is specifically expressed in the testis. It belongs to the SelWTH family, which possesses a thioredoxin-like fold and a conserved CxxU (C is cysteine, U is Sec) motif, suggesting a redox function for this gene. Alternatively spliced transcript variants have been found for this gene.

Source: NCBI Gene 348303 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 69 total
  • MANE Select transcript: NM_182704

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30399
Approved symbolSELENOV
Nameselenoprotein V
Location19q13.2
Locus typegene with protein product
StatusApproved
AliasesSELV
Ensembl geneENSG00000186838
Ensembl biotypeprotein_coding
OMIM607919
Entrez348303

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 1 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000335426, ENST00000597876, ENST00000600586

RefSeq mRNA: 2 — MANE Select: NM_182704 NM_001350809, NM_182704

CCDS: CCDS54266

Canonical transcript exons

ENST00000335426 — 6 exons

ExonStartEnd
ENSE000013395753951890339518977
ENSE000020525743951860839518632
ENSE000035028583951907139519170
ENSE000036688513951874039518793
ENSE000039782353952014639520675
ENSE000039782363951513939516021

Expression profiles

Bgee: expression breadth broad, 60 present calls, max score 79.25.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1483 / max 18.9456, expressed in 92 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1757890.121582
1757880.02683

Top tissues by expression

100 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453379.25gold quality
right testisUBERON:000453478.14gold quality
testisUBERON:000047378.13gold quality
left lobe of thyroid glandUBERON:000112072.99gold quality
thyroid glandUBERON:000204672.96gold quality
right lobe of thyroid glandUBERON:000111972.66gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099170.83gold quality
mucosa of stomachUBERON:000119950.67gold quality
temporal lobeUBERON:000187149.44gold quality
anterior cingulate cortexUBERON:000983549.42gold quality
amygdalaUBERON:000187649.34gold quality
nucleus accumbensUBERON:000188247.95gold quality
calcaneal tendonUBERON:000370147.59silver quality
hypothalamusUBERON:000189847.29gold quality
superior frontal gyrusUBERON:000266146.73gold quality
Ammon’s hornUBERON:000195446.32gold quality
putamenUBERON:000187446.04gold quality
left ovaryUBERON:000211945.80gold quality
colonic epitheliumUBERON:000039745.57gold quality
cerebral cortexUBERON:000095645.37gold quality
prefrontal cortexUBERON:000045145.21gold quality
frontal cortexUBERON:000187045.01gold quality
ovaryUBERON:000099244.88gold quality
pituitary glandUBERON:000000744.17gold quality
right frontal lobeUBERON:000281044.05gold quality
brainUBERON:000095543.97gold quality
dorsolateral prefrontal cortexUBERON:000983443.84gold quality
right ovaryUBERON:000211843.26gold quality
C1 segment of cervical spinal cordUBERON:000646942.94gold quality
primary visual cortexUBERON:000243642.92silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.12

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

16 targeting SELENOV, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-426799.9666.532368
HSA-MIR-6887-3P99.6667.831778
HSA-MIR-6837-5P99.2565.471632
HSA-MIR-4685-5P99.2565.991563
HSA-MIR-427999.1966.702437
HSA-MIR-442699.1766.741949
HSA-MIR-4662B98.3366.371163
HSA-MIR-464798.3066.411139
HSA-MIR-365297.7165.431890
HSA-MIR-192-3P97.5267.661001
HSA-MIR-443097.4765.611813
HSA-MIR-60097.0766.731259
HSA-MIR-7161-3P96.7968.79798
HSA-MIR-61796.7965.96738
HSA-MIR-452295.7666.23742
HSA-MIR-49294.0264.46413

Literature-anchored findings (GeneRIF, showing 1)

  • The SS concentrations that lead to a decrease in the viability of human prostate adenocarcinoma cells (line Du-145) have been selected, and the effect of sodium selenite on the expression of mRNA of the SELV, SELW, and TGR selenocysteine proteins in these cells has been analyzed. (PMID:29989584)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusSelenovENSMUSG00000046750
rattus_norvegicusSelenovENSRNOG00000051208

Paralogs (2): MIEN1 (ENSG00000141741), SELENOW (ENSG00000178980)

Protein

Protein identifiers

Selenoprotein VP59797 (reviewed: P59797)

All UniProt accessions (2): M0QZN9, P59797

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in a redox-related process.

Tissue specificity. Testis specific.

Post-translational modifications. Truncated SELENOV proteins produced by failed UGA/Sec decoding are ubiquitinated by the CRL2(APPBP2) complex, which recognizes the glycine (Gly) at the C-terminus of truncated SELENOV proteins.

Similarity. Belongs to the SelWTH family.

RefSeq proteins (2): NP_001337738, NP_874363* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR011893Selenoprotein_Rdx-typFamily
IPR036249Thioredoxin-like_sfHomologous_superfamily
IPR051441SelW_relatedFamily

Pfam: PF10262

UniProt features (7 total): region of interest 2, chain 1, compositionally biased region 1, non-standard amino acid 1, cross-link 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

No AlphaFold model available for P59797 — AlphaFold DB does not currently provide models for proteins above ~3000 aa.

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 270–273

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 37 (showing top): CAGGTCC_MIR492, KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_MEF_HCP_WITH_H3K27ME3, ZNF282_TARGET_GENES, ZNF664_TARGET_GENES, MIR4426, MIR7161_3P, MIR4647_MIR4662B, GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP, GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN, WP_SELENIUM_MICRONUTRIENT_NETWORK, DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS, DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS

GO Biological Process (1): response to selenium ion (GO:0010269)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): cytosol (GO:0005829)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
response to chemical1
binding1
cytoplasm1
cellular anatomical structure1

Protein interactions and networks

STRING

362 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SELENOVSELENOTP62341873
SELENOVSELENOKQ9Y6D0854
SELENOVSELENOHQ8IZQ5852
SELENOVSELENOOQ9BVL4831
SELENOVSELENOSQ9BQE4804
SELENOVSELENOFO60613799
SELENOVSELENOIQ9C0D9796
SELENOVSEPHS2Q99611789
SELENOVSELENONQ9NZV5776
SELENOVSELENOMQ8WWX9775
SELENOVSECISBP2Q96T21762
SELENOVMSRB1Q9NZV6738
SELENOVTXNRD3Q86VQ6730
SELENOVSELENOPP49908669
SELENOVTXNRD1Q16881624

IntAct

34 interactions, top by confidence:

ABTypeScore
SELENOVZMYND19psi-mi:“MI:0915”(physical association)0.720
ZMYND19SELENOVpsi-mi:“MI:0915”(physical association)0.720
SELENOVPRR20Cpsi-mi:“MI:0915”(physical association)0.560
GOLGA2SELENOVpsi-mi:“MI:0915”(physical association)0.560
SELENOVZMIZ2psi-mi:“MI:0915”(physical association)0.560
SELENOVAPPBP2psi-mi:“MI:0915”(physical association)0.560
PRR20CSELENOVpsi-mi:“MI:0915”(physical association)0.560
ZMIZ2SELENOVpsi-mi:“MI:0915”(physical association)0.560
APPBP2SELENOVpsi-mi:“MI:0915”(physical association)0.560
SELENOVGOLGA2psi-mi:“MI:0915”(physical association)0.560
HSF2BPSELENOVpsi-mi:“MI:0915”(physical association)0.560
SELENOVEFHC1psi-mi:“MI:0915”(physical association)0.560
SELENOVPIN1psi-mi:“MI:0915”(physical association)0.560
SELENOVNTAQ1psi-mi:“MI:0915”(physical association)0.560
SELENOVQRICH1psi-mi:“MI:0915”(physical association)0.560
ZMYND19SELENOVpsi-mi:“MI:0915”(physical association)0.000
HSF2BPSELENOVpsi-mi:“MI:0915”(physical association)0.000
EFHC1SELENOVpsi-mi:“MI:0915”(physical association)0.000
PIN1SELENOVpsi-mi:“MI:0915”(physical association)0.000
NTAQ1SELENOVpsi-mi:“MI:0915”(physical association)0.000
QRICH1SELENOVpsi-mi:“MI:0915”(physical association)0.000

BioGRID (14): SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), QRICH1 (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Affinity Capture-Western)

ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A0A494C071, A6NNC1, A6QL64, B3KS81, D3YZV8, E2RYF7, E9Q6E9, F1LWT0, F8W0I5, O60732, P0C8Z4, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18751, P20930, P43537, P53353, P59797, P62521, Q01456, Q08AG5, Q12816, Q3BBV2, Q5H9R4, Q5HY64, Q5JPF3, Q6P902, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8BGJ3, Q8N307, Q8N7U7, Q8N7X1

Diamond homologs: D0EYG3, O19097, P59797, P63300, P63301, P63302, P63303, Q148C8, Q568W0, Q5NVB2, Q95KL4, Q9BRT3, Q9CQ86, Q9STZ2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

69 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance62
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

827 predictions. Top by Δscore:

VariantEffectΔscore
19:39516019:CTGG:Cdonor_loss1.0000
19:39516020:TGGTG:Tdonor_loss1.0000
19:39516021:GGTG:Gdonor_loss1.0000
19:39516022:G:Cdonor_loss1.0000
19:39516022:G:GGdonor_gain1.0000
19:39518738:A:AGacceptor_gain1.0000
19:39518739:G:GGacceptor_gain1.0000
19:39519062:T:TAacceptor_gain1.0000
19:39516023:T:Adonor_loss0.9900
19:39518579:A:AGacceptor_gain0.9900
19:39518580:A:Gacceptor_gain0.9900
19:39518592:T:Aacceptor_gain0.9900
19:39518598:T:TAacceptor_gain0.9900
19:39518606:A:AGacceptor_gain0.9900
19:39518607:G:GGacceptor_gain0.9900
19:39518607:GT:Gacceptor_gain0.9900
19:39518739:GT:Gacceptor_gain0.9900
19:39518739:GTA:Gacceptor_gain0.9900
19:39518739:GTAC:Gacceptor_gain0.9900
19:39518794:G:GGdonor_gain0.9900
19:39518988:G:GGdonor_gain0.9900
19:39519006:G:Tdonor_gain0.9900
19:39519064:T:TAacceptor_gain0.9900
19:39519069:AGAG:Aacceptor_gain0.9900
19:39519069:AGAGG:Aacceptor_gain0.9900
19:39519070:GAGG:Gacceptor_gain0.9900
19:39519070:GAGGG:Gacceptor_gain0.9900
19:39516017:TACTG:Tdonor_gain0.9800
19:39516020:TG:Tdonor_gain0.9800
19:39516021:GG:Gdonor_gain0.9800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000046545 (19:39519590 C>T), RS1000967317 (19:39516575 T>C), RS1000997495 (19:39515627 C>G,T), RS1001375560 (19:39520531 A>G), RS1001445444 (19:39515110 TCG>T), RS1001560716 (19:39518036 G>A), RS1001851542 (19:39513506 C>A), RS1002536506 (19:39513689 C>T), RS1002854153 (19:39516059 A>T), RS1002971551 (19:39518954 G>A,C), RS1003917037 (19:39518922 A>C), RS1004089935 (19:39513431 T>C), RS1004351057 (19:39518585 C>G,T), RS1005614396 (19:39520206 G>A), RS1005816991 (19:39514393 G>A,C)

Disease associations

OMIM: gene MIM:607919 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Valproic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.